![Pascale Malgouyres](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pascale Malgouyres was the founder and the Executive Vice Chairman-Marketing Development at Poxel SA, a company founded in 2009.
Ms. Malgouyres also held former positions as the Director-Glucophage Global Marketing at Merck Serono SpA, Principal at Eli Lilly & Co., and Head-Rheumatology Marketing Programs at Procter & Gamble Pharmaceuticals France SASU.
Ms. Malgouyres received undergraduate, graduate, and doctorate degrees from the University of Lyon.
| Sociétés | Poste | Fin |
|---|---|---|
Procter & Gamble Pharmaceuticals France SASU
 Procter & Gamble Pharmaceuticals France SASU Medical DistributorsDistribution Services Wholesales personal care products | Corporate Officer/Principal | - |
Merck Serono SpA
 Merck Serono SpA Pharmaceuticals: MajorHealth Technology Produces specialty pharmaceuticals | Sales & Marketing | - |
| POXEL | Fondateur | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 5 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Poxel SA
 Poxel SA Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, focuses on the development of novel treatments for serious chronic diseases | Health Technology |
University of Lyon
 University of Lyon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Procter & Gamble Pharmaceuticals France SASU
Procter & Gamble Pharmaceuticals France SASU Medical DistributorsDistribution Services Wholesales personal care products | Distribution Services |
Merck Serono SpA
Merck Serono SpA Pharmaceuticals: MajorHealth Technology Produces specialty pharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
